Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Cytokine Signaling Pathways and Interactions, and Protein Kinase Regulation and GTPase Signaling.
Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signaling
Novel water-soluble and highly efficient dual type I/II next generation inhibitors of FMS-like tyrosine kinase 3 (FLT3)
Chemical proteomics reveals the target landscape of 1,000 kinase inhibitors
Optimization of the Lead Compound NVP‐BHG712 as a Colorectal Cancer Inhibitor
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS
ProteomicsDB: a multi-omics and multi-organism resource for life science research
Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms
Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors
Kinobeads: A Chemical Proteomic Approach for Kinase Inhibitor Selectivity Profiling and Target Discovery
CiRCus: A Framework to Enable Classification of Complex High-Throughput Experiments
Adaptive Resistance to EGFR-Targeted Therapy by Calcium Signaling in NSCLC Cells
The target landscape of clinical kinase drugs